These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 33144648)

  • 21. Clinical pharmacogenetics and potential application in personalized medicine.
    Zhou SF; Di YM; Chan E; Du YM; Chow VD; Xue CC; Lai X; Wang JC; Li CG; Tian M; Duan W
    Curr Drug Metab; 2008 Oct; 9(8):738-84. PubMed ID: 18855611
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacogenomic profile of a central European urban random population-Czech population.
    Proietti R; Maranho Neto GA; Kunzova S; Lo Re O; Ahola-Olli A; Heliste J; Gonzalez-Rivas JP; Vinciguerra M
    PLoS One; 2023; 18(4):e0284386. PubMed ID: 37079615
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variability of
    Mutawi TM; Zedan MM; Yahya RS; Zakria MM; El-Sawi MR; Gaedigk A
    Pharmacogenomics; 2021 Apr; 22(6):323-334. PubMed ID: 33789449
    [No Abstract]   [Full Text] [Related]  

  • 24. Longitudinal exposure of English primary care patients to pharmacogenomic drugs: An analysis to inform design of pre-emptive pharmacogenomic testing.
    Kimpton JE; Carey IM; Threapleton CJD; Robinson A; Harris T; Cook DG; DeWilde S; Baker EH
    Br J Clin Pharmacol; 2019 Dec; 85(12):2734-2746. PubMed ID: 31454087
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeted next generation sequencing as a tool for precision medicine.
    Gulilat M; Lamb T; Teft WA; Wang J; Dron JS; Robinson JF; Tirona RG; Hegele RA; Kim RB; Schwarz UI
    BMC Med Genomics; 2019 Jun; 12(1):81. PubMed ID: 31159795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive Allele Genotyping in Critical Pharmacogenes Reduces Residual Clinical Risk in Diverse Populations.
    Luo S; Jiang R; Grzymski JJ; Lee W; Lu JT; Washington NL
    Clin Pharmacol Ther; 2021 Sep; 110(3):759-767. PubMed ID: 33930192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cyrius: accurate CYP2D6 genotyping using whole-genome sequencing data.
    Chen X; Shen F; Gonzaludo N; Malhotra A; Rogert C; Taft RJ; Bentley DR; Eberle MA
    Pharmacogenomics J; 2021 Apr; 21(2):251-261. PubMed ID: 33462347
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacogenomics in Asians: Differences and similarities with other human populations.
    Biswas M; Jinda P; Sukasem C
    Expert Opin Drug Metab Toxicol; 2023 Jan; 19(1):27-41. PubMed ID: 36755439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Arylamine N-acetyltransferase-2 genotypes in the Thai population.
    Kukongviriyapan V; Prawan A; Tassaneyakul W; Aiemsa-Ard J; Warasiha B
    Br J Clin Pharmacol; 2003 Mar; 55(3):278-81. PubMed ID: 12630978
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain.
    Casajús A; Zubiaur P; Alday E; Soria-Chacartegui P; Saiz-Rodríguez M; Gutierrez L; Aragonés C; Campodónico D; Gómez-Fernández A; Navares-Gómez M; Villapalos-García G; Mejía-Abril G; Ochoa D; Abad-Santos F
    Clin Transl Sci; 2024 Jan; 17(1):e13698. PubMed ID: 38140786
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of genetic variants of CYP2D6, CYP2C9, CYP2C19 and CYP3A4 on antiepileptic drug metabolism in pediatric patients with refractory epilepsy.
    López-García MA; Feria-Romero IA; Serrano H; Rayo-Mares D; Fagiolino P; Vázquez M; Escamilla-Núñez C; Grijalva I; Escalante-Santiago D; Orozco-Suarez S
    Pharmacol Rep; 2017 Jun; 69(3):504-511. PubMed ID: 28343093
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of exposure to pharmacogenetic drugs by the Saudis treated at the health care centers of the Ministry of National Guard.
    Alshabeeb MA; Alyabsi M; Paras B
    Saudi Pharm J; 2022 Aug; 30(8):1181-1192. PubMed ID: 36164570
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CYP450 Genotype/Phenotype Concordance in Mexican Amerindian Indigenous Populations-Where to from Here for Global Precision Medicine?
    de Andrés F; Sosa-Macías M; Ramos BPL; Naranjo MG; LLerena A
    OMICS; 2017 Sep; 21(9):509-519. PubMed ID: 28873029
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drinking Ethanol Has Few Acute Effects on CYP2C9, CYP2C19, NAT2, and P-Glycoprotein Activities but Somewhat Inhibits CYP1A2, CYP2D6, and Intestinal CYP3A: So What?
    Gazzaz M; Kinzig M; Schaeffeler E; Jübner M; Hsin CH; Li X; Taubert M; Trueck C; Iltgen-Breburda J; Kraus D; Queckenberg C; Stoffel M; Schwab M; Sörgel F; Fuhr U
    Clin Pharmacol Ther; 2018 Dec; 104(6):1249-1259. PubMed ID: 29633238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Frequencies of pharmacogenomic alleles across biogeographic groups in a large-scale biobank.
    Li B; Sangkuhl K; Whaley R; Woon M; Keat K; Whirl-Carrillo M; Ritchie MD; Klein TE
    Am J Hum Genet; 2023 Oct; 110(10):1628-1647. PubMed ID: 37757824
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluating the frequency and the impact of pharmacogenetic alleles in an ancestrally diverse Biobank population.
    Verma SS; Keat K; Li B; Hoffecker G; Risman M; ; Sangkuhl K; Whirl-Carrillo M; Dudek S; Verma A; Klein TE; Ritchie MD; Tuteja S
    J Transl Med; 2022 Nov; 20(1):550. PubMed ID: 36443877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Results of the implementation of a pharmacogenomics platform based on NGS technologies. Combining clinical and research approaches.
    Ramudo-Cela L; Busto-Fernández F; Outeda-Macías M; Antolín S; Calvo-Martínez L; Martín-Herranz I
    Farm Hosp; 2021 Dec; 45(7):11-37. PubMed ID: 35379108
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacogenomic landscape of Indian population using whole genomes.
    Sahana S; Bhoyar RC; Sivadas A; Jain A; Imran M; Rophina M; Senthivel V; Kumar Diwakar M; Sharma D; Mishra A; Sivasubbu S; Scaria V
    Clin Transl Sci; 2022 Apr; 15(4):866-877. PubMed ID: 35338580
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
    Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
    Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CYP2C19 and CYP2D6 genotypes in Pacific peoples.
    Helsby NA
    Br J Clin Pharmacol; 2016 Nov; 82(5):1303-1307. PubMed ID: 27304207
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.